Ovid Therapeutics (OVID) Shares Outstanding (Diluted) (2020 - 2026)
Ovid Therapeutics (OVID) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - | 52.24 Mn |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn | 256.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - | 680.00 |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn | 64.41 Mn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | 198.10 Mn |
| 10 | Ovid Therapeutics | 120.41 Mn | -35.11 Mn | - | 70.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.98 Mn |
| Dec 31, 2025 | 70.98 Mn |
| Sep 30, 2025 | 70.98 Mn |
| Jun 30, 2025 | 70.98 Mn |
| Mar 31, 2025 | 70.98 Mn |
| Dec 31, 2024 | 70.98 Mn |
| Sep 30, 2024 | 70.98 Mn |
| Jun 30, 2024 | 71.20 Mn |
| Mar 31, 2024 | 70.72 Mn |
| Dec 31, 2023 | 70.58 Mn |
| Sep 30, 2023 | 70.62 Mn |
| Jun 30, 2023 | 70.53 Mn |
| Mar 31, 2023 | 70.49 Mn |
| Dec 31, 2022 | 70.42 Mn |
| Sep 30, 2022 | 70.43 Mn |
| Jun 30, 2022 | 70.39 Mn |
| Mar 31, 2022 | 70.35 Mn |
| Dec 31, 2021 | 68.07 Mn |
| Sep 30, 2021 | 67.93 Mn |
| Jun 30, 2021 | 67.82 Mn |